Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Xiao-Xu Zhu"'
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Hypertension is a risk factor for cholangiocarcinoma (CCA). The effect of anti-hypertensive drugs on the prognosis of CCA is not clear. Methods This is a retrospective study of 102 patients (56.9% males, median age 66 years) diagn
Externí odkaz:
https://doaj.org/article/fcb805a64b85483a8a30286ec3d5a118
Autor:
Jian‐Hui Li, Xiao Wu, Xuhao Ni, Ya‐Xiong Li, Long Xu, Xiao‐Yi Hao, Wei Zhao, Xiao‐Xu Zhu, Xiao‐Yu Yin
Publikováno v:
Clinical and Translational Medicine, Vol 13, Iss 3, Pp n/a-n/a (2023)
Abstract Background Intrahepatic cholangiocarcinoma (iCCA) is a highly lethal malignancy characterized by massive fibrosis and has ineffective adjuvant therapies. Here, we demonstrate the potential of angiotensin receptor blockers (ARBs) in targeting
Externí odkaz:
https://doaj.org/article/56d307785f16435ab4b42bb6b325e6c1
Autor:
Fu-Rong Yang, Xiao-Xu Zhu, Ming-Wang Kong, Xiao-Juan Zou, Qing-Yu Ma, Xiao-Juan Li, Jia-Xu Chen
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Many studies have proven that autophagy plays a pivotal role in the development of depression and it also affects the expression of GLUT4 in the hypothalamus. Xiaoyaosan has been shown to exert antidepressant effects in a variety of ways, but its und
Externí odkaz:
https://doaj.org/article/e0b67352968643808f758d0e363b37e7
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Neutrophil infiltration plays an important role in the initial phase of hepatic ischemia and reperfusion injury (HIRI). Despite many different key molecules that have been reported to meditate neutrophil trafficking in HIRI, the mechanism of this pro
Externí odkaz:
https://doaj.org/article/2e92f7e99ccc4b398b27a82b4be2bb6a
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
The gut microbiota is a complex group of microorganisms that is not only closely related to intestinal immunity but also affects the whole immune system of the body. Antimicrobial peptides and reactive oxygen species participate in the regulation of
Externí odkaz:
https://doaj.org/article/5955f16f46354aebbf51785837d9f44b
Autor:
Jian-Hui Li, Xiao-Xu Zhu, Fu-Xi Li, Chen-Song Huang, Xi-Tai Huang, Jie-Qin Wang, Zhuo-Xing Gao, Shi-Jin Li, Qiong-Cong Xu, Wei Zhao, Xiao-Yu Yin
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-15 (2019)
Abstract Background Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver cancer. The dismal outcome of ICC patients is due to lack of early diagnosis, the aggressive biological behavior of ICC and the lack of effective therap
Externí odkaz:
https://doaj.org/article/91a3d852af01463193074dfd61c4b636
Autor:
Xiao Wu, Jian-Hui Li, Long Xu, Ya-Xiong Li, Xiao-Xu Zhu, Xi-Yu Wang, Xingmei Wu, Wei Zhao, Xuhao Ni, Xiao-Yu Yin
Publikováno v:
Cell Death & Differentiation.
In the past few decades, advances in the outcomes of patients suffering from pancreatic ductal adenocarcinoma (PDAC) have lagged behind these gained in the treatment of many other malignancies. Although the pivotal role of the SUMO pathway in PDAC ha
Autor:
Jian‐Hui Li, Xiao Wu, Xuhao Ni, Ya‐Xiong Li, Long Xu, Xiao‐Yi Hao, Wei Zhao, Xiao‐Xu Zhu, Xiao‐Yu Yin
Publikováno v:
Clinical and Translational Medicine. 13
Autor:
Qiong-Cong Xu, Xiao-Yu Yin, Jian-Hui Li, Zhuo-Xing Gao, Xiao-Xu Zhu, Chen-Song Huang, Xi-Tai Huang, Wei Zhao
Publikováno v:
Cancer Letters. 518:196-206
Pancreatic ductal adenocarcinoma (PDAC) is a malignancy with poor prognosis due to early metastasis. The aberrant N6-methyladenosine (m6A) RNA modification has emerged as an important mechanism in cancer progression and metastasis, but its role in PD
Autor:
Xiao‐Xu Zhu, Jian‐Hui Li, Xuhao Ni, Xiao Wu, Xun Hou, Ya‐Xiong Li, Shi‐Jin Li, Wei Zhao, Xiao‐Yu Yin
Publikováno v:
Cancer science. 113(11)
Pancreatic ductal adenocarcinoma (PDAC) is a highly fatal malignancy with extremely poor prognosis. Gemcitabine resistance is a major challenge in the treatment of PDAC. Here, we showed that LINC00460 was associated with the response to gemcitabine b